Expression of the multidrug resistance genes in the liver

FASEB Journal

Volumn 11, Issue 5, 1997, Pages 308-313

  Silverman, Jeffrey A ^a   Schrenk, Dieter ^b  

^a AvMax Inc   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

basal regulation; liver; mdr; P glycoprotein

Indexed keywords

CARRIER PROTEIN; GLYCOPROTEIN P; ABC TRANSPORTER; MULTIDRUG RESISTANCE PROTEIN 3;

GENE EXPRESSION REGULATION; HUMAN; LIVER METABOLISM; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; XENOBIOTIC METABOLISM; ANIMAL; BIOSYNTHESIS; GENE EXPRESSION; GENETICS; INTRAHEPATIC BILE DUCT; METABOLISM; MOUSE; RAT; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BILE CANALICULI; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION; HUMANS; MICE; P-GLYCOPROTEIN; P-GLYCOPROTEINS; RATS;

EID: 0030939088     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.5.9141496     Document Type: Review

References (55)

1. Endicott, J. A., and Ling, V. (1989) The biochemistry of P-glycoprotein mediated multidrug resistance. Annu. Rev. Biochem. 58, 137-171
2. Borst, P., Schinkel, A. H., Smit, J. J. M., Wagenaar, E., Van Deemter, L., Smith, A. J., Eijdems, W. H. M., Baas, F., and Zaman, G. J. R. (1993) Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol. Ther. 60, 289-299
3. Gottesman, M. M., and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427
4. Silverman, J. A., and Thorgeirsson, S. S. (1995) Regulation and function of the multidrug resistance genes in liver. In Progress in Liver Diseases (Boyer, J. L., Ockner, R. K., eds) pp. 101-124, W. B. Saunders, Philadelphia
5. Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., Berns, and A. J. M., Borst, P. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77, 491-502
6. Buschman, E., Arceci, R. J., Croop, J. M., Che, M., Arias, I. M., Houseman, D. E., and Gros, P. (1992) mdr2 Encodes P-glycoprotein expressed in the bile canalicular membrane as determined by isoform-specific antibodies. J. Biol. Chem. 267, 18093-18099
7. Croop, J. M., Raymond, M., Haber, D., Devault, A., Arceci, R. J., Gros, P., and Housman, D. E. (1989) The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell. Biol. 9, 1345-1350
8. Brown, P. C., Thorgeirsson, S. S., and Silverman, J. A. (1993) Cloning and regulation of the rat mdr2 gene. Nucleic Acids Res. 21, 3885-3891
9. Smit, J. J. M., Schinkel, A. H., Oude Elferink, R. P. J., Groen, A. K., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., Ottenhoff, R., van der Lugt, N. M. T., van der Valk, M. A., van Roon, M. A., Offerhaus, G. J. A., Berns, A. J. M., and Borst, P. (1993) Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell 75, 451-462
10. Mauad, T. H., van Nieuwkerk, C. M. J., Dingemans, K. P., Smit, J. J. M., Schinkel, A. H., Notenboom, R. G. E., van den Bergh Weerman, M. A., Verkruisen, R. P., Groen, A. K., Oude Elferink, R. P. J., Borst, P., and Offerhaus, G. J. A. (1994) Mice with homozygous disruption of the mdr2 P-glycoprotein gene: A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am. J. Pathol. 145, 1237-1245
11. Ruetz, S., and Gros, P. (1994) Phosphotidylcholine translocase: A physiological role for the mdr2 gene. Cell 77, 1071-1081
12. Arias, I. M., Gatmaitan, Z., Mazzanti, R., Shu, H., and Kumamoto, Y. (1991) Structure and function of P-glycoprotein in the normal liver and intestine. In Xenobiotics and Canter (Ernster, L., ed) pp. 229-239, Japan Sci. Soc. Press, Tokyo
13. Goldstein, L. J., Galski, H., Fojo, A. T., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G. M., Lieber, M., Cossman, J., Gottesman, M. M., and Pastan, I. (1989) Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81, 116-124
14. Chenivesse, X., Franco, D., and Bréchot, C. (1993) MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis. J. Hepatol. 18, 168:172
15. Itsubo, M., Ishikawa, T., Toda, G., and Tanaka, M. (1993) Immunohistochemical study of expression and the cellular localization of the multidrug resistance gene product P-glycoprotein in primary liver carcinoma. Cancer 73, 298-303
16. Shen, D.-W., Lu, Y.-G., Chin, K.-V., Pastan, I., and Gottesman, M. M. (1991) Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MDR1 gene expression. J. Cell Sci. 98, 317-322
17. Park, J.-G., Lee, S.-K., Hong, I.-G., Kim, H.-S., Lim, K.-H., Choe, K.-J., Kim, W.-H., Kim, Y.-I., Tsuruo, T., and Gottesman, M. M. (1994) MDR1 gene expression: Its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines. J. Natl. Cancer Inst. 86, 700-705
18. Burt, R. K., and Thorgeirsson, S. S. (1988) Conduction of MDR-1 multidrug resistance and cytochrome P-450 genes in rat liver by xenobiotics. J. Natl. Cancer Inst. 80, 1381-1386
19. Hill, B. A., Brown, P. C., Preisegger, K.-H., Silverman, J. A. (1996) Regulation of mdr1b gene expression in Fischer, Wistar and Sprague-Dawley rats in vivo and in vitro. Carcinogenesis 17, 451-457
20. Gant, T. W., Silverman, J. A., Bisgaard, H. C., Burt, R. K., Marino, P. A., and Thorgeirsson, S. S. (1991) Regulation of 2-acetylaminofluorene and 3-methylcholanthrene mediated induction of mdr and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcingen. 4, 499-509
21. Schrenk, D., Gant, T. W., Michalke, A., Orzechowski, A., Silverman, J. A., Battula, N., and Thorgeirsson, S. S. (1994) Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells. Carcinogenesis 15, 2541-2546
22. Schuetz, E. G., Schuetz, J. D., Thompson, M. T., Fisher, R. A., Madariage, J. R., and Strom, S. C. (1995) Phenotypic variability in induction of P-glycoprotein mRNA by aromatic hydrocarbons in primary human hepatocytes. Mol. Carcinog. 12, 61-65
23. Wacher, V. J., Wu, C.-Y., and Benet, L. Z. (1995) Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinog. 13, 129-134
24. Schuetz, E. G., Beck, W. T., and Schuetz, J. D. (1996) Modulators and substrates of P-glycoprotein and cytochrome p4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49, 311-318
25. Schuetz, J. D., Silvennan, J. A., Thottassery, J. V., Furuya, K. N., and Schuetz, E. G. (1995) Divergent regulation of the class II P-glycoprotein gene in primary cultures of hepatocytes versus H35 hepatoma by glucocorticoids. Cell Growth & Differ. 6, 1321-1332
26. Fardel, O., Lecureur, V., and Guillouzo, A. (1993) Regulation by dexamethasone of P-glycoprotein expression in cultured rat hepatocytes. FEBS Lett. 327, 189-193
27. Chapekar, M. S., Hugget, A. C., and Cheng, C. (1991) Dexamethasone prevents the growth inhibitory effects of recombinant tumor necrosis factor in a rat hepatomea cell line Reuber-RC-3: An association with the changes in the messenger RNA levels for multidrug resistance gene. Biochem. Biophys. Res. Commun. 181, 1524-1531
28. Hirsch-Ernst, K. I., Ziemann, C., Schmitz-Salue, C., Foth, H., and Kahl, G. F. (1995) Modulation of P-glycoprotein and mdr1b expression by growth factors in primary rat hepatocyte culture. Biochem. Biophys. Res. Commun. 215, 179-185
29. Fardel, O., Morel, F., and Guillouzo, A. (1993) P-glycoprotein expression in human, mouse, hamster and rat hepatocytes in primary culture. Carcinogenesis 14, 781-783
30. Gant, T. W., Silverman, J. A., and Thorgeirsson, S. S. (1992) Regulation of P-glycoprotein gene expression in hepatocytes and liver cell lines by a trans-acting transcriptional repressor. Nucleic Acids Res. 20, 2841-2846
31. Schuetz, J. D., Strom, S. C., and Schuetz, E. G. (1995) Induction of P-glycoprotein by protein synthesis inhibition is not controlled by a transcriptional repressor protein in rat and human liver cells. J. Cell. Physiol. 165, 261-272
32. Thorgeirsson, S. S., Huber, B. E., Sorrell, S., Fojo, A. T., Pastan, I., and Gottesman, M. M. (1987) Expression of the multidrug-resistance gene in hepatocarcinogenesis and regenerating rat liver. Science 236, 1120-1122
33. Nakatsukasa, H., Silverman, J. A., Gant, T. W., Evarts, R. P., and Thorgeirsson, S. S. (1993) Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hepatology 18, 1202-1207
34. Marino, P. A., Gottesman, M. M., and Pastan, I. (1989) Regulation of the multidrug resistance gene in regenerating rat liver. Cell Growth & Differ. 1, 57-62
35. Schrenk, D., Gant, T. W., Preisegger, K.-H., Silverman, J. A., Marino, P., and Thorgeirsson, S. S. (1993) Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Hepatology 17, 854-860
36. Gosland, M., Tsuboi, C., Hoffman, T., Goodin, S., and Vore, M. (1993) 17β-Estradiol glucuronide: An inducer of cholestasis and a physiological substrate for the multidrug resistance transporter. Cancer Res. 53, 5382-5385
37. Fairchild, C. R., Ivy, S. P., Rushmore, T., Lee, G., Koo, P., Goldsmith, M. E., Myers, C., Farber, E., and Cowan, K. H. (1987) Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 84, 7701-7705
38. Nakatsukasa, H., Evarts, R. P., Burt, R. K., and Nagy, P., Thorgeirsson, S. S. (1992) Cellular pattern of multidrug-resistance gene expression during chemical hepatocarcinogenesis in the rat. Mol. Carcinog. 6, 190-198
39. Bradley, G., Sharma, R., Rajalakshmi, S., and Ling, V. (1992) P-Glycoprotein expression during tumor progression in the rat liver. Cancer Res. 52, 5154-5161
40. Volm, M., Zerban, H., Mattern, J., and Efferth, T. (1990) Overexpression of P-glycoprotein in rat hepatocellular carcinomas. Carcinogesis 11, 169-172
41. Teeter, L. D., Estes, M., Chan, J. Y., Atassi, H., Sell, S., Becker, F. F., and Kuo, M. T. (1993) Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol. Carcinog. 8, 67-73
42. Miyamoto, K.-I., Wakusawa, S., Nakamura, S., Tajima, K., and Hidaka, H. (1992) Multidrug resistance in Yoshida rat ascites hepatoma cell lines. Anticancer Res. 12, 649-654
43. Thorgeirsson, S. S., Gant, T. W., and Silverman, J. A. (1994) Transcriptional regulation of multidrug resistance gene expression. In Anticancer Drug Resistance (Goldstein, L. J., Ozols, R. F., eds) pp. 57-68. Kluwer Academic, Norwell
44. Teeter, L. D., Eckersburg, T., Tsai, Y., and Kuo, M. T. (1991) Analysis of the Chinese hamster P-glycoprotein/multidrug resistance gene pgp1 reveals that the AP-1 site is essential for full promoter activity. Cell Growth & Differ. 2, 429-437
45. Ikeguchi, M., Teeter, L. D., Eckersberg, T., Ganapathi, R., and Kuo, M. T. (1991) Structural and functional analyses of the promoter of the murine multidrug resistance gene mdr3/mdr1a reveal a negative element containing the AP-1 binding site. DNA Cell Biol. 10, 639-649
46. Cohen, D., Piekarz, R., Hsu, S. I.-H., DePinho, R. A., Carrasco, N., and Horwitz, S. B. (1991) Structural and functional analysis of the mouse mdr1b gene promoter. J. Biol. Chem. 254, 2239-2244
47. Silverman, J. A., and Hill, B. A. (1995) Characterization of the basal and carcinogen regulatory elements of the rat mdr1b promoter. Mol. Carcinog. 13, 50-59
48. Goldsmith, M. E., Madden, M. J., Morrow, C. S., and Cowan, K. H. (1993) A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene. J. Biol. Chem. 268, 5856-5860
49. Yu, L., Wu, Q., Yang, C.-P. H., and Horwitz, S. B. (1995) Coordination of transcription factors, NF-Y and C/EBPβ, in the regulation of the mdr1b promoter. Cell Growth & Differ. 6, 1505-1512
50. Combates, N. J., Rzepka, R. W., Chen, Y.-N. P., and Cohen, D. (1994) NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter. J. Biol. Chem. 269, 29715-29719
51. Kohno, K., Sato, S., Takano, H., Matsuo, K., and Kuwano, M. (1989) The direct activation of human multidrug resistance gene by anticancer agents. Biochem. Biophys. Res. Commun. 164, 1415-1421
52. Chin, K.-V., Tanaka, S., Darlington, G., Pastan, I., and Gottesman, M. M. (1990) Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem. 265, 221-226
53. Morrow, C. S., Nakagawa, M., Goldsmith, M. E., Madden, M. J., and Cowan, K. H. (1994) Reversible transcription activation of mdr1 by sodium butyrate treatment of human colon cancer cells. J. Biol. Chem. 269, 10739-10746
54. McCoy, C., Smith, D. E., and Cornwell, M. M. (1995) 12-O-Tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol. Cell. Biol. 15, 6100-6108
55. Smit, J. J. M., van Deemter, L., Wagenaar, E., Schinkel, A. H., and Borst, P. (1995) Characterization of the promoter region of the human MDR3 P-glycoprotein gene. Biochim. Biophys. Acta 1261, 44-56